ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
14 announcements
Deepak Chemtex's 29th AGM on September 21, 2026 adopted FY25-26 financials and re-appointed its MD and WTD. Routine resolutions including subsidiary RPT approval were passed.
Deepak Chemtex Ltd has notified shareholders with unregistered email IDs of the weblink to access the AGM notice and Annual Report for the upcoming meeting.
Deepak Chemtex Ltd has filed its Integrated Annual Report for FY 2025-26, incorporating the notice for the 29th Annual General Meeting scheduled for September 21, 2026.
Deepak Chemtex Ltd's 29th Annual General Meeting is scheduled for September 21, 2026, via video conferencing. The agenda includes director appointments and related-party transaction approvals.
Deepak Chemtex approved the Directors' Report for the year ended March 31, 2026. The board also scheduled the company's 29th AGM for September 21, 2026.
Mrs. Sonam Sharma has resigned as Company Secretary and Compliance Officer of Deepak Chemtex Limited effective August 17, 2026, due to unavoidable circumstances.
Deepak Chemtex Limited re-appointed Saurabh Deepak Arora as Chairperson & Managing Director and Trishla Baid Arora as Whole Time Director for a 36-month term.
Deepak Chemtex announced the re-appointment of Mr. Saurabh Deepak Arora as MD and Mrs. Trishla Baid Arora as Whole-time Director for three years starting July 28, 2026.
Deepak Chemtex confirmed the non-applicability of the Annual Secretarial Compliance Report for FY26. This exemption applies to the company as a listed SME under SEBI regulations.
Deepak Chemtex Limited appointed M/s. ADMS and Company as Internal Auditor for FY 2026-27. This regulatory appointment ensures continued internal audit compliance and governance.
Deepak Chemtex Ltd reported revenue from operations of ₹36.7 Cr (-9.6% YoY) and net profit of ₹4.1 Cr (-40.6% YoY) for H2 FY26.
Deepak Chemtex reported a standalone pre-tax profit of ₹8.93 Crore for FY26. The board approved audited results, showing sustained operations across its chemical segments.
Deepak Chemtex scheduled a board meeting for May 29, 2026, to approve audited financial results. The trading window remains closed for designated persons.
Deepak Chemtex Ltd clarified to BSE that recent stock price and volume movements are purely market-driven. The company confirmed it has no undisclosed information under Regulation 30 that could impact trading behavior and remains in compliance with all listing regulations.